サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609713

日本のペプチド治療薬市場レポート：タイプ別、メーカータイプ別、合成技術別、投与経路別、用途別、地域別、2025年～2033年

Japan Peptide Therapeutics Market Report by Type, Types of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 119 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
日本のペプチド治療薬市場レポート：タイプ別、メーカータイプ別、合成技術別、投与経路別、用途別、地域別、2025年～2033年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 119 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のペプチド治療薬市場の市場規模は2024年に25億9,270万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに47億7,620万米ドルに達し、2025年から2033年にかけて6.37%の成長率（CAGR）を示すと予測しています。糖尿病を治療するための迅速かつ正確な治療法に対するニーズの高まりと、皮膚老化の影響を緩和するための美容整形に対する個人の志向の高まりが、主に市場成長の原動力となっています。

本レポートで扱う主な質問

  • 日本のペプチド治療薬市場はこれまでどのように推移してきたか、また今後どのように推移していくか？
  • COVID-19が日本のペプチド治療薬市場に与えた影響は？
  • 日本のペプチド治療薬市場のタイプ別の内訳は？
  • 日本のペプチド治療薬市場のメーカータイプ別の内訳は？
  • 日本のペプチド治療薬市場の合成技術別の内訳は？
  • 日本のペプチド治療薬市場の投与経路別の内訳は？
  • 日本のペプチド治療薬市場の用途別の内訳は？
  • 日本のペプチド治療薬市場のバリューチェーンにはどのような段階がありますか？
  • 日本のペプチド治療薬の主な促進要因と課題は何か？
  • 日本のペプチド治療薬市場の構造と主要プレーヤーは？
  • 日本のペプチド治療薬市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のペプチド治療薬市場-イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のペプチド治療薬市場情勢

  • 過去および現在の市場動向（2019年～2024年）
  • 市場予測（2025-2033）

第6章 日本のペプチド治療薬市場：タイプ別の内訳

  • イノベーティブ
  • ジェネリック

第7章 日本のペプチド治療薬市場：メーカータイプ別の内訳

  • アウトソーシング
  • 社内

第8章 日本のペプチド治療薬市場：合成技術別の内訳

  • 固相ペプチド合成
  • 液相ペプチド合成
  • ハイブリッド技術

第9章 日本のペプチド治療薬市場：投与経路別の内訳

  • 非経口
  • 経口
  • その他

第10章 日本のペプチド治療薬市場：用途別の内訳

  • 胃腸障害
  • 神経疾患
  • 代謝障害
  • がん
  • その他

第11章 日本のペプチド治療薬市場：競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第12章 主要企業のプロファイル

第13章 日本のペプチド治療薬市場- 業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第14章 付録

目次
Product Code: SR112024A18531

Japan peptide therapeutics market size reached USD 2,592.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 4,776.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.37% during 2025-2033. The inflating need for fast and precise treatment methods to cure diabetes, along with the increasing inclination among individuals towards cosmetic procedures to mitigate the effects of skin aging, is primarily driving the market growth.

Peptides are highly effective and specific signaling molecules that attach to particular cell surface receptors, including ion channels and G protein-coupled receptors (GPCRs), initiating intracellular responses. In the pharmaceutical sector, they are utilized to develop innovative regenerative therapies capable of targeting various types of cells and influencing their reactions. These therapies, in comparison to other treatment alternatives, are less toxic, generally safe, and well-tolerated. Consequently, they are becoming increasingly popular in clinical applications throughout Japan for the treatment of conditions such as cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.

Japan Peptide Therapeutics Market Trends:

The increasing prevalence of both acute and chronic illnesses, alongside improved access to medical services, stands as a prominent factor that is positively impacting the demand for peptides in the development of innovative therapies, which is primarily driving the market growth. Additionally, peptides are employed in cosmeceutical procedures to mitigate the effects of skin aging. This, combined with the growing awareness among individuals about their physical appearance and the desire to maintain youthful and healthy skin, is propelling the adoption of cosmetic treatments and peptide-based therapeutics worldwide. Furthermore, the introduction of new synthetic techniques that reduce the frequency of injections and enhance the stability and other physical attributes of peptide therapeutics has led to their widespread use in injections for diabetic patients. This, in conjunction with the increasing incidence of diabetes and a preference for rapid and precise treatment methods , is driving the utilization of peptide therapeutics over oral medications. Moreover, the emerging trend of personalized and targeted therapies is driving the demand for versatile peptide-based materials, which is acting as another significant growth-inducing factor. Alongside this, the growing investment in the development of novel peptide therapeutics for autoimmune and inflammatory conditions is expected to create a favorable market outlook in the coming years.

Japan Peptide Therapeutics Market Segmentation:

Type Insights:

  • Innovative
  • Generic

Type of Manufacturer Insights:

  • Outsourced
  • In-house

Synthesis Technology Insights:

  • Solid Phase Peptide Synthesis
  • Liquid Phase Peptide Synthesis
  • Hybrid Technology

Routes of Administration Insights:

  • Parenteral
  • Oral
  • Others

Application Insights:

  • Gastrointestinal Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Cancer
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan peptide therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan peptide therapeutics market?
  • What is the breakup of the Japan peptide therapeutics market on the basis of type?
  • What is the breakup of the Japan peptide therapeutics market on the basis of type of manufacturer?
  • What is the breakup of the Japan peptide therapeutics market on the basis of synthesis technology?
  • What is the breakup of the Japan peptide therapeutics market on the basis of routes of administration?
  • What is the breakup of the Japan peptide therapeutics market on the basis of application?
  • What are the various stages in the value chain of the Japan peptide therapeutics market?
  • What are the key driving factors and challenges in the Japan peptide therapeutics?
  • What is the structure of the Japan peptide therapeutics market and who are the key players?
  • What is the degree of competition in the Japan peptide therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Peptide Therapeutics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Peptide Therapeutics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Peptide Therapeutics Market - Breakup by Type

  • 6.1 Innovative
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Generic
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)

7 Japan Peptide Therapeutics Market - Breakup by Type of Manufacturer

  • 7.1 Outsourced
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 In-house
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan Peptide Therapeutics Market - Breakup by Synthesis Technology

  • 8.1 Solid Phase Peptide Synthesis
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Liquid Phase Peptide Synthesis
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Hybrid Technology
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)

9 Japan Peptide Therapeutics Market - Breakup by Routes of Administration

  • 9.1 Parenteral
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Oral
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Others
    • 9.3.1 Historical and Current Market Trends (2019-2024)
    • 9.3.2 Market Forecast (2025-2033)

10 Japan Peptide Therapeutics Market - Breakup by Application

  • 10.1 Gastrointestinal Disorders
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2019-2024)
    • 10.1.3 Market Forecast (2025-2033)
  • 10.2 Neurological Disorders
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2019-2024)
    • 10.2.3 Market Forecast (2025-2033)
  • 10.3 Metabolic Disorders
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2019-2024)
    • 10.3.3 Market Forecast (2025-2033)
  • 10.4 Cancer
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2019-2024)
    • 10.4.3 Market Forecast (2025-2033)
  • 10.5 Others
    • 10.5.1 Historical and Current Market Trends (2019-2024)
    • 10.5.2 Market Forecast (2025-2033)

11 Japan Peptide Therapeutics Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Product Portfolio
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Peptide Therapeutics Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix